<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03491423</url>
  </required_header>
  <id_info>
    <org_study_id>HANNEQUIN APPARA 2016</org_study_id>
    <nct_id>NCT03491423</nct_id>
  </id_info>
  <brief_title>Short and Fast Step Test: Feasibility, Validity and Tolerance of a Functional Evaluation Test of Lactic Anaerobic Capacities in Patients With Coronary Artery Disease</brief_title>
  <acronym>CORANAE</acronym>
  <official_title>Short and Fast Step Test: Feasibility, Validity and Tolerance of a Functional Evaluation Test of Lactic Anaerobic Capacities in Patients With Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recommendations for cardiovascular rehabilitation (CVR) encourage exercise training,&#xD;
      primarily involving the aerobic system, to allow patients to regain independence in daily&#xD;
      activities. However, the lactic anaerobic process is also involved during these activities&#xD;
      (stair climbing, carrying loads, etc.). Hence there is a major interest in accurately&#xD;
      assessing patients' anaerobic capacities in order to tailor suitable exercise programs.&#xD;
      However, there are no functional tests specifically dedicated to the evaluation of lactic&#xD;
      anaerobic metabolism and adapted to people with coronary disease. The investigators offer a&#xD;
      dedicated test, the short and fast test (SFST), which can be applied in current clinical&#xD;
      practice and has already been evaluated in a population of healthy subjects. The purpose of&#xD;
      this project is to evaluate the safety, feasibility and validity of SFST in a population of&#xD;
      patients with coronary artery disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 4, 2018</start_date>
  <completion_date type="Actual">May 3, 2019</completion_date>
  <primary_completion_date type="Actual">May 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of patients who completed the SFST without complications</measure>
    <time_frame>through study completion, an average of 11 days</time_frame>
    <description>- Absence of muscular or bone-joint disorders quantified according to the VAS. The exercise will be considered as not tolerated if pain is reported during the test and/or at day 3 (VASâ‰¥6).&#xD;
AND no falls or stumbling related trauma&#xD;
AND absence of cardiovascular or blood pressure events:&#xD;
Hypertension (systolic pressure greater than 250 mmHg (O'Brien et al. 2005) or hypotension with clinical consequences (malaise or feeling unwell)&#xD;
Discomfort, chest pain, onset of vascular claudication&#xD;
Rhythm or conduction disorders or repolarization abnormalities, at a higher frequency than that observed in the pre-inclusion stress test&#xD;
Abnormal increase in heart rate (greater than the maximum rate determined during the stress test).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Coronary Artery Disease Without Heart Failure</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Short and fast step test without measurement of pulmonary gas exchange</intervention_name>
    <description>For one minute, the patient should climb up and down a 17.5 cm high step as quickly as possible while holding onto a bar in front of the step.</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>glucose meter</intervention_name>
    <description>glucose meter to measure lactatemia</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ECG / heart rate</intervention_name>
    <description>ECG and heart rate (HR) collection by telemetry</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaires</intervention_name>
    <description>VAS pain assessment and evaluation of effort perception according to Borg's scale</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Short and fast step test with measurement of pulmonary gas exchange</intervention_name>
    <description>For one minute, the patient should climb up and down a 17.5 cm high step as quickly as possible while holding onto a bar in front of the step.</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Patient who has given oral consent Adult patient (male or female) with coronary artery&#xD;
        disease without heart failure referred for rehabilitation program Left ventricular ejection&#xD;
        fraction (Simpson method) &gt; 45%.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Protected adult&#xD;
&#xD;
          -  Patient not affiliated to a national health insurance scheme&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
&#xD;
          -  Orthostatic hypotension&#xD;
&#xD;
          -  Severe obstructive heart disease&#xD;
&#xD;
          -  aortic valve narrowing&#xD;
&#xD;
          -  Progressive severe cardiac rhythm or conduction disorders not requiring a device,&#xD;
             detected during the initial stress test.&#xD;
&#xD;
          -  intracavitary cardiac thrombus&#xD;
&#xD;
          -  severe pulmonary arterial hypertension (systolic pulmonary hypertension &gt;70mmHg)&#xD;
&#xD;
          -  recent venous thromboembolic history (last 3 months)&#xD;
&#xD;
          -  heart transplantation&#xD;
&#xD;
          -  associated medical condition that can predominantly impair functional and respiratory&#xD;
             capacities (examples: unstabilized metabolic disorders such as progressive renal&#xD;
             failure, significant asthenia related to a severe unstabilized condition such as&#xD;
             neoplasia, systemic disease, chronic obstructive pulmonary disease...)&#xD;
&#xD;
          -  physical impairments of the lower limbs hindering the test, whether neurological&#xD;
             (central or peripheral), arterial (in particular, arteriopathy of the lower limbs with&#xD;
             systolic index &lt; 0.6) or orthopedic (degenerative or inflammatory rheumatism)&#xD;
&#xD;
          -  Treatment with Corticosteroids, Anabolics, or L-Carnitine.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de DIJON</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>March 30, 2018</study_first_submitted>
  <study_first_submitted_qc>April 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2018</study_first_posted>
  <last_update_submitted>September 3, 2019</last_update_submitted>
  <last_update_submitted_qc>September 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

